THE LATEST

GRABAR LAW OFFICE FILES SHAREHOLDER DERIVATIVE COMPLAINT AGAINST THE OFFICERS AND DIRECTORS OF PAYPAL HOLDINGS, INC.

By Grabar Law | Nov 4, 2022

This stockholder derivative action is brought on behalf of PayPal against certain current and former PayPal executives and members of ...

Analyzing The Information Through Digital Podium

GRABAR LAW OFFICE FILES SHAREHOLDER DERIVATIVE COMPLAINT AGAINST THE OFFICERS AND DIRECTORS OF ABBOTT LABORATORIES INC.

By Grabar Law | Oct 7, 2022

As alleged in the Complaint, During the Relevant Period, the Individual Defendants breached their fiduciary duties and violated the federal ...

Files Complaint Against The Officers and Directors

Grabar Law Office Files Shareholder Derivative Complaint Against the Officers and Directors of Romeo Power Inc. (NYSE: RMO)

By Grabar Law | Jul 29, 2022

As alleged in the Complaint, the Company repeatedly represented that it had “secured $300 million in revenue” (a figure that ...

Complaint Against The Lucid Group Directors

Grabar Law Office Files Shareholder Derivative Complaint Against the Officers and Directors of Lucid Group, Inc. (NASDAQ: LCID)

By Grabar Law | Jul 29, 2022

It is alleged the Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts ...

Grabar Law Office Files Shareholder Derivative Complaint Against Officers and Directors of QuantumScape Corporation

By Grabar Law | Jun 10, 2022

This stockholder derivative action is brought on behalf of QuantumScape against certain current and former members of the Company’s Board ...

Grabar Law Office Files Shareholder Derivative Complaint Against Officers and Directors of Intrusion, Inc.

By Grabar Law | Jun 8, 2022

This stockholder derivative action is brought on behalf of Intrusion, Inc. against certain members of the Company’s Board of Directors ...

GRABAR LAW OFFICE INVESTIGATES POTENTIAL CLAIMS AGAINST OFFICERS AND DIRECTORS OF VOLTA, INC. (NYSE: VLTA)

By Grabar Law | May 13, 2022

A federal securities fraud class action against complaint has been filed Against Volta, Inc. and certain of its officers and ...

GRABAR LAW OFFICE INVESTIGATES POTENTIAL CLAIMS AGAINST OFFICERS AND DIRECTORS OF ODONATE THERAPEUTICS, INC. AFTER AN AGREEMENT IS REACHED TO SETTLE CLASS ACTION

By Grabar Law | May 10, 2022

Odonate Therapeutics Inc. (OTC: ODTC) has agreed to pay $12.5 million to resolve a proposed securities class action in alleging ...

GRABAR LAW OFFICE FILES COMPLAINT PURSUANT TO 8 DEL. C. § 220 TO COMPEL INSPECTION OF BOOKS AND RECORDS OF CLOVER HEALTH INVESTMENTS CORP.

By Grabar Law | Apr 30, 2022

Plaintiff wishes to inspect books and records relating to meetings of Clover Health’s Board of Directors (the “Board”) regarding materially ...

Take A Look At the automatic Cars On The Road

GRABAR LAW OFFICE FILES COMPLAINT PURSUANT TO 8 DEL. C. § 220 TO COMPEL INSPECTION OF BOOKS AND RECORDS OF QUANTUMSCAPE CORPORATION

By Grabar Law | Mar 11, 2022

According to the Complaint, Plaintiff wishes to inspect books and records relating to meetings of QuantumScape’s Board of Directors (the ...

« Previous
1
…
4
5
6
7
8
…
16
Next »

Grabar Law Office In the News: Alto Neuroscience Execs Sued Over Rosy Drug Claims

By Grabar Law | Oct 9, 2025

An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company's lead ...

Grabar Law Office In the News: Marijuana Vape Antitrust Actions Consolidated In Calif.

By Grabar Law | Oct 9, 2025

Five proposed antitrust class actions brought by buyers of CCell brand cannabis vape accusing the Chinese manufacturers and U.S. distributors ...

Grabar Law Office In the News: DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe

By Grabar Law | Oct 9, 2025

The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...

Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims

By Grabar Law | Aug 26, 2025

Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...

Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims

By Grabar Law | Aug 26, 2025

Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...

Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania

By Grabar Law | Jul 11, 2025

Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...

Grabar Law Office In the News: Geron Shareholder Sues Execs Over Drug Launch Claims

By Grabar Law | Apr 19, 2025

A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...

Grabar Law Office In the News: AI Audio Co. Brass Accused of Acquisition Accounting Errors

By Grabar Law | Apr 19, 2025

Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...